Cabergoline Ratiopharm

Cabergoline Ratiopharm is a medication used primarily for conditions related to hyperprolactinemia. It works by reducing prolactin levels in the body, offering relief from associated symptoms. This oral medication is manufactured by Ratiopharm Gmbh and is available in the EU market.

Cabergoline is commonly used to treat hyperprolactinemia, a condition characterized by elevated prolactin levels. This can lead to symptoms such as irregular menstrual cycles, infertility, and galactorrhea. Additionally, cabergoline may be prescribed for conditions like Parkinson's disease to manage symptoms. The primary use of cabergoline is to normalize prolactin levels and alleviate related symptoms.

Common effects of cabergoline may include nausea, dizziness, and headache. Some users might experience fatigue or digestive issues. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Cabergoline should be handled with care, especially by individuals with a history of heart disease or psychiatric disorders. It is important to follow the prescribed dosage and administration instructions. Pregnant or breastfeeding women should consult a healthcare provider before using cabergoline.

Cabergoline may interact with certain medications, including those that affect liver enzymes. Alcohol and other sedatives should be avoided as they can enhance the sedative effects of cabergoline. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.